跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,327 条关于
“Tesaro (GSK)”
全部
4,327
临床试验
2,625
药物
1,048
机构
35
资讯
619
10个月前
GSK Subsidiary Tesaro Files Lawsuit Against AnaptysBio Over Jemperli License Breach
10个月前
GSK and AnaptysBio File Dueling Lawsuits Over Jemperli Royalty Agreement as Cancer Drug Nears Blockbuster Status
3个月前
Alteogen Posts Record H1 2026 Revenue as Keytruda SC Sales Surge 262% and Platform Deals Expand
12天前
Alteogen licenses ALT-B4 to Novartis in deal worth up to $3.2 billion
去年
GSK's TIM-3 Inhibitor Cobolimab Fails Phase III Trial in Advanced Lung Cancer
去年
Tesaro's Niraparib Approved for Ovarian Cancer Maintenance Therapy
2年前
GSK Licenses Hansoh Pharma's B7-H3 ADC, HS-20093, for $185 Million Upfront
去年
FDA Approves J&J's Akeega for BRCA-Positive Metastatic Prostate Cancer
去年
GSK Acquires Efimosfermin for $1.2 Billion to Target Steatotic Liver Disease
9年前
GSK's GSK5764227 Receives FDA Breakthrough Therapy Designation for Osteosarcoma
第 1 页,共 62 页
上一页
下一页